JBS (JBS) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
1 Feb, 2026Executive summary
Net revenue reached $19.3 billion in Q2 2024, up 6.8% year-over-year, with adjusted EBITDA of $1.9 billion and net profit of $329 million, reversing a loss in 2Q23.
Adjusted EBITDA margin rose to 9.8%, up 4.8 percentage points year-over-year, and gross margin improved to 15.4% from 11.1% in 2Q23.
Free cash flow was $1.1 billion, a 315% increase year-over-year, reversing Q1 cash consumption and generating $431 million year-to-date.
Dividend distribution of $0.037 per share and interim dividend of $808 million ($0.30 per share) announced.
Diversification strategy drove results, with 75% of EBITDA from poultry and pork, especially Pilgrim's, Seara, and JBS USA Pork.
Financial highlights
Net debt reduced to $14.8 billion, down $1.9 billion year-over-year, with leverage dropping to 2.77x from 3.66x sequentially and 4.21x year-over-year.
Capital expenditures were $346 million, 63% allocated to maintenance, and 37% to expansion.
Operating cash flow for the quarter was $1.8 billion, up from $1.1 billion in 2Q23.
Export revenue grew 2.4% year-over-year to $4.9 billion, with Asia accounting for 48% of exports.
Cash and equivalents stood at $3.9 billion, with $3.3 billion in undrawn credit lines and total liquidity of $7.2 billion.
Outlook and guidance
Leverage expected to continue declining, potentially below 2.5x in Q3 and close to 2x by year-end.
Management expects continued benefits from diversification, operational improvements, and investments in innovation and capacity expansion.
Domestic demand in Brazil is expected to remain strong into 2025, with continued investment in value-added and innovative products.
Grain prices are expected to remain stable, supporting margins if supply-demand balance holds.
Strategic emphasis on value-added and branded products to improve growth and margin profile.
Latest events from JBS
- Net sales up 11% to $21.6B; EBITDA margins fell, but Seara and Brazil remained strong.JBS
Q1 202619 May 2026 - Global protein leader with $88.3B revenue, margin growth, and expanding global footprint.JBS
Investor presentation18 May 2026 - Record 2025 revenue and net income, with global expansion offsetting margin pressures.JBS
Q4 202515 May 2026 - Global protein leader with $88.3B revenue, expanding through diversification and strategic investment.JBS
Investor presentation13 May 2026 - Record 3Q24: $19.9B revenue, $2.2B EBITDA, $693M profit, leverage at 2.15x.JBS
Q3 202413 Jan 2026 - Record revenue, margin expansion, and lower leverage highlight robust 2024 performance.JBS
Q4 202420 Dec 2025 - Record revenue and net income growth offset margin pressures in US beef and pork.JBS
Q2 202523 Nov 2025 - Record profit and sales, strong poultry and pork margins, and dual listing plans despite beef headwinds.JBS
Q1 202518 Nov 2025 - Record sales rose 13% to $22.6B, but margins and profitability declined in Q3.JBS
Q3 202514 Nov 2025